Neutral
ALX Oncology (NASDAQ: ALXO) awards 800,000 options to chief officer
ALX Oncology Holdings Inc. (NASDAQ: ALXO) has granted its Chief Development & Operating Officer, Jeff E. Knight, 800,000 stock options with an exercis...